What BioVie Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 4 | 4 |
| Sells | 0 | 0 |
| Total trades | 4 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 23,280 | 23,280 |
| Disposed | 0 | 0 |
| Net activity | +23,280 | +23,280 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Palumbo Joseph M | Chief Medical Officer | Aug 28 | Open-market buy · P | +4,843 | $2.16 | +$10.5K | 6,036 |
| Chappell Amy Suzon | Director | Aug 28 | Open-market buy · P | +727 | $2.16 | +$1.57K | 727 |
| Kim Joanne Wendy | Chief Financial Officer | Aug 28 | Open-market buy · P | +2,500 | $2.18 | +$5.45K | 3,441 |
| Do Cuong V | President & CEO | Aug 27 | Open-market buy · P | +15,210 | $2.08 | +$31.6K | 16,117 |
| Do Cuong V | President & CEO | Aug 07 | Open-market buy · P | +5,000 | — | — | 9,992 |
| Rogich Sigmund | Director | Nov 20 | Grant / award · A | +32,700 | — | — | 36,926 |
| Berman Richard J | Director | Nov 20 | Grant / award · A | +34,200 | — | — | 40,643 |
| Kim Joanne Wendy | Chief Financial Officer | Jun 24 | Withheld — tax / exercise cost · F | −18,250 | $0.47 | −$8.65K | 93,940 |
| Kim Joanne Wendy | Chief Financial Officer | Jun 24 | Grant / award · A | +73,000 | — | — | 112,196 |
| Palumbo Joseph M | Chief Medical Officer | Jun 24 | Withheld — tax / exercise cost · F | −29,000 | $0.47 | −$13.7K | 119,196 |
| Palumbo Joseph M | Chief Medical Officer | Jun 24 | Grant / award · A | +116,000 | — | — | 148,196 |
| Do Cuong V | President & CEO | Jun 24 | Withheld — tax / exercise cost · F | −42,000 | $0.47 | −$19.9K | 551,948 |
| Do Cuong V | President & CEO | Jun 24 | Grant / award · A | +168,000 | — | — | 593,948 |
| Do Cuong V | President & CEO | Mar 04 | Open-market buy · P | +10,000 | — | — | 435,854 |
| Kim Joanne Wendy | Chief Financial Officer | Feb 15 | Withheld — tax / exercise cost · F | −2,476 | $1.18 | −$2.92K | 39,196 |
| Palumbo Joseph M | Chief Medical Officer | Feb 15 | Withheld — tax / exercise cost · F | −2,476 | $1.18 | −$2.92K | 32,196 |
| Do Cuong V | President & CEO | Feb 15 | Withheld — tax / exercise cost · F | −4,953 | $1.18 | −$5.84K | 425,948 |
| Kim Joanne Wendy | Chief Financial Officer | Dec 11 | Grant / award · A | +5,000 | — | — | 44,148 |
| Gorlin Steve | Director | Dec 01 | Open-market sale · S | −75,680 | $1.69 | −$128K | 46,358 |
| Do Cuong V | President & CEO | Nov 30 | Open-market buy · P | +10,000 | $1.78 | +$17.8K | 68,759 |
Loading...
